Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up.
Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up.
复制标题
DOI：
10.1370/afm.7
复制
发表时间：
2003-05-01
影响因子：
4.4
通讯作者：
Hawley, Sarah T
中科院分区：
文献类型：
--
作者：
Volk, Robert J;Spann, Stephen J;Hawley, Sarah T
目得：前列腺癌筛查的有效性尚不确定，专业组织建议教育患者了解潜在的危害和益处。我们评估的效果，录像带决策援助促进知情的决策，前列腺癌筛查在初级保健patients.METHODS：一组160名男性，45至70岁，没有前列腺癌的历史，随机查看或不查看20分钟的教育录像带之前，在一所大学的家庭医学诊所的例行办公室访问。受试者再次联系1年后，他们的访问，以评估他们收到的前列腺癌筛查（直肠指检[DRE]或前列腺特异性抗原[PSA]检测），他们的满意度与他们的筛选决定，和知识的保留，因为基线assessment.RESULTS：随访评估完成了87.5%的干预组和83.8%的对照组。DRE的发生率在两组之间没有差异。70例干预受试者中有24例（34.3%）报告了前列腺特异性抗原检测，67例对照受试者中有37例（55.2%）报告了前列腺特异性抗原检测（P = .01）。非裔美国男性（9/16，56.3%）比白色男性（13/46，28.3%）更有可能进行PSA检测（P = 0.044）。对筛选决定的满意度在研究组之间没有差异。干预组受试者比对照组受试者更了解前列腺癌筛查，尽管这些差异在1年内下降（P < .001）。结论：前列腺癌筛查的决策辅助工具对筛查行为有长期影响，并似乎促进知情决策。
PURPOSE: The efficacy of prostate cancer screening is uncertain, and professional organizations recommend educating patients about potential harms and benefits. We evaluated the effect of a videotape decision aid on promoting informed decision making about prostate cancer screening among primary care patients.METHODS: A group of 160 men, 45 to 70 years of age, with no history of prostate cancer, were randomized to view or not to view a 20-minute educational videotape before a routine office visit at a university-based family medicine clinic. The subjects were contacted again 1 year after their visit to assess their receipt of prostate cancer screening (digital rectal examination [DRE] or prostate-specific antigen [PSA] testing), their satisfaction with their screening decision, and knowledge retention since the baseline assessment.RESULTS: Follow-up assessments were completed for 87.5% of the intervention subjects and 83.8% of the control subjects. The rate of DRE did not differ between the 2 groups. Prostate-specific antigen testing was reported by 24 of 70 (34.3%) intervention subjects and 37 of 67 (55.2%) control subjects (P = .01). African American men were more likely to have had PSA testing (9 of 16, 56.3%) than were white men (13 of 46, 28.3%) (P = .044). Satisfaction with the screening decision did not differ between the study groups. Intervention subjects were more knowledgeable of prostate cancer screening than were control subjects, although these differences declined within 1 year (P < .001).CONCLUSIONS: Decision aids for prostate cancer screening can have a long-term effect on screening behavior and appear to promote informed decision making.